4.7 Review

Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2

期刊

出版社

MDPI
DOI: 10.3390/ijms232314779

关键词

myotonic dystrophy type 1 (DM1); myotonic dystrophy type 2 (DM2); gastrointestinal dysfunction; smooth muscle; alternative splicing

向作者/读者索取更多资源

Myotonic dystrophy (DM) is a highly variable multisystemic disorder that affects one in 8000 individuals. Although most research has focused on the symptoms and pathological mechanisms in muscle and brain, surveys have found a high prevalence of gastrointestinal (GI) symptoms in DM patients. Clinical studies have identified chronic and progressive dysfunction in various parts of the GI system. The pathological mechanisms leading to this dysfunction are not well understood, but it is suggested that misregulation of alternative splicing in smooth muscle may contribute to GI dysfunction in DM.
Myotonic dystrophy (DM) is a highly variable, multisystemic disorder that clinically affects one in 8000 individuals. While research has predominantly focused on the symptoms and pathological mechanisms affecting striated muscle and brain, DM patient surveys have identified a high prevalence for gastrointestinal (GI) symptoms amongst affected individuals. Clinical studies have identified chronic and progressive dysfunction of the esophagus, stomach, liver and gallbladder, small and large intestine, and rectum and anal sphincters. Despite the high incidence of GI dysmotility in DM, little is known regarding the pathological mechanisms leading to GI dysfunction. In this review, we summarize results from clinical and molecular analyses of GI dysfunction in both genetic forms of DM, DM type 1 (DM1) and DM type 2 (DM2). Based on current knowledge of DM primary pathological mechanisms in other affected tissues and GI tissue studies, we suggest that misregulation of alternative splicing in smooth muscle resulting from the dysregulation of RNA binding proteins muscleblind-like and CUGBP-elav-like is likely to contribute to GI dysfunction in DM. We propose that a combinatorial approach using clinical and molecular analysis of DM GI tissues and model organisms that recapitulate DM GI manifestations will provide important insight into defects impacting DM GI motility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据